Almac Sciences, a member of the Almac Group, has completed a roughly $7 million investment in a new two-storey center for biocatalysis, flow chemistry technologies and peptide research and development.   Almac Sciences has grown rapidly over the last 5 years with significant investments in its non-GMP and GMP manufacturing plants to support increased client manufacturing demands. Adding to this growth, the first phase of expansion for technology development has been completed with the opening of...